STRASBOURG, France--(BUSINESS WIRE)--Regulatory News:
Transgene SA (PARIS:TNG) today announced its financial results1 for the six-month period ended June 30, 2015.
Revenue for the six-month period ended June 30, 2015 amounted to €5.3 million, compared to €6.1 million for the same period in 2014. Government financing for research expenditures accounted for the majority of revenue, with €4.5 million for the first six months of 2015 compared to €5.0 million for the same period in 2014.
Help employers find you! Check out all the jobs and post your resume.
Transgene SA (PARIS:TNG) today announced its financial results1 for the six-month period ended June 30, 2015.
Revenue for the six-month period ended June 30, 2015 amounted to €5.3 million, compared to €6.1 million for the same period in 2014. Government financing for research expenditures accounted for the majority of revenue, with €4.5 million for the first six months of 2015 compared to €5.0 million for the same period in 2014.
Help employers find you! Check out all the jobs and post your resume.
